
Profitability, historical returns, and peer comparisons.
According to Nxera Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -8.51%. This represents a change of 277.77% compared to the average of -2.25% of the last 4 quarters.
The mean historical ROE of Nxera Pharma Co., Ltd. over the last ten years is -2.05%. The current -8.51% ROE has changed 314.51% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's ROE was at its highest in in the December 2022 quarter at 6.23%. The ROE was at its lowest in in the December 2025 quarter at -12.66%.
Average
-2.05%
Median
-2.39%
Minimum
-20.54%
Maximum
33.97%
Discovering the peaks and valleys of Nxera Pharma Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 252.06%
Maximum Annual ROE = 33.97%
Minimum Annual Increase = -1732.88%
Minimum Annual ROE = -20.54%
| Year | ROE | Change |
|---|---|---|
| 2025 | -20.54% | 190.93% |
| 2024 | -7.06% | -34.42% |
| 2023 | -10.77% | -1732.88% |
| 2022 | 0.66% | -62.74% |
| 2021 | 1.77% | -37.32% |
| 2020 | 2.82% | -11.12% |
| 2019 | 3.18% | -116.62% |
| 2018 | -19.11% | 252.06% |
| 2018 | -5.43% | -115.99% |
| 2017 | 33.97% | -648.93% |
The current ROE of Nxera Pharma Co., Ltd. (SOLTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.79%
5-year avg
-7.19%
10-year avg
-2.05%
Nxera Pharma Co., Ltd.’s ROE is less than Astellas Pharma Inc. (20.41%), less than Daiichi Sankyo Company, Limited (16.51%), less than Chugai Pharmaceutical Co., Ltd. (25.03%), less than Shionogi & Co., Ltd. (14.36%), less than Kyowa Kirin Co., Ltd. (9.54%), less than Ono Pharmaceutical Co., Ltd. (8.69%), less than Eisai Co., Ltd. (4.77%), less than Sumitomo Pharma Co., Ltd. (13.02%), less than Santen Pharmaceutical Co., Ltd. (13.39%), less than KYORIN Holdings, Inc. (1.56%),
| Company | ROE | Market cap |
|---|---|---|
| 20.41% | $4.79T | |
| 16.51% | $5.61T | |
| 25.03% | $11.83T | |
| 14.36% | $2.72T | |
| 9.54% | $1.37T | |
| 8.69% | $1.17T | |
| 4.77% | $1.49T | |
| 13.02% | $932.63B | |
| 13.39% | $604.65B | |
| 1.56% | $66.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nxera Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nxera Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Nxera Pharma Co., Ltd.'s ROE?
How is the ROE calculated for Nxera Pharma Co., Ltd. (SOLTF)?
What is the highest ROE for Nxera Pharma Co., Ltd. (SOLTF)?
What is the 3-year average ROE for Nxera Pharma Co., Ltd. (SOLTF)?
What is the 5-year average ROE for Nxera Pharma Co., Ltd. (SOLTF)?
How does the current ROE for Nxera Pharma Co., Ltd. (SOLTF) compare to its historical average?